Global Channel Management
The Bioprocess Scientist (Downstream) supports the purification and characterization of viral vectors, biologics, and recombinant proteins for process development and manufacturing activities. This role requires hands-on experience with purification techniques and analytical methods to ensure successful project outcomes. The position involves managing multiple tasks to meet project timelines while maintaining strong documentation standards.
Headquarters
Atlanta, Georgia, United States
Company Size
11-50 employees
Founded
2009
Global Channel Management, Inc. is a technology and services company specializing in recruiting, staff augmentation, federal contract management, and service management solutions. They serve federal government agencies, Department of Defense installations, and commercial enterprises, helping organizations source skilled professionals and deliver mission-critical services. Their tailored solutions address fluctuating staffing needs, expertise gaps, and operational requirements to optimize efficiency and reduce labor costs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Global Channel Management.
Global Channel Management didn’t post a salary, so this is our estimate from similar listings.
25% below the average for this role
Downstream Viral Vector Process Development Scientist
GenScript
Senior Research Associate I (Temporary) – Biologics Purification & Characterization
biomarin
BioProcess Engineer II, Downstream
ImmunityBio
Scientist in Downstream Bioprocess Development
Zoetis
Associate Scientist - Process Development
Eli Lilly and Company
Research Associate, Antibody & Protein Purification, R&D UK Centre (Cambridge), Research and Development, Orion Pharma
Orion Pharma